<Disease><Name>CEROID LIPOFUSCINOSIS, NEURONAL, 1 (SANTAVUORI-HALTIA-DISEASE)</Name><Synonym>CLN1; CEROID LIPOFUSCINOSIS, NEURONAL, 1, VARIABLE AGE AT ONSET</Synonym><OMIM><Number>256730</Number><URL>http://omim.org/entry/256730</URL></OMIM><Orphanet><Number>228329</Number><URL>http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=EN&amp;Expert=228329</URL></Orphanet><Protein><Number>Palmitoyl-protein thioesterase 1; PPT1</Number><URL>http://www.uniprot.org/uniprot/P50897</URL></Protein><ExPASy><Number>3.1.2.2</Number><URL>http://enzyme.expasy.org/EC/3.1.2.2</URL></ExPASy><Gene>1p34.2</Gene><ICD>E75.4</ICD><Summary>rare ;autosomal recessive;- classic infantile-onset;- late Infantile- and juvenile-onset;- adult-onset</Summary><Symptoms><symtomp><id>3424</id><symptom>abnormal movement</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1942</id><symptom>ataxia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1955</id><symptom>behavior, hyperactive, restless / behaviour, hyperactive, restless</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2211</id><symptom>blindness, visual loss, visual impairment</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1966</id><symptom>cerebellar atrophy or hypoplasia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2226</id><symptom>cerebral atrophy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1945</id><symptom>chorea or athetosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2401</id><symptom>conjunctival biopsy, abnormal</symptom><category>LABORATORY FINDINGS | LABORATORY FINDINGS</category></symtomp><symtomp><id>2247</id><symptom>contractures, joints</symptom><category>GENERAL TOPICS | SKELETAL DEFECT</category></symtomp><symtomp><id>2117</id><symptom>CT, brain, abnormalities [-] / CT, kraniell, abnormal </symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3165</id><symptom>dementia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3645</id><symptom>depression</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3816</id><symptom>developmental regression</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2164</id><symptom>dysarthria</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1946</id><symptom>dystonia</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2423</id><symptom>early death</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2160</id><symptom>EEG abnormalities [-]</symptom><category>LABORATORY FINDINGS</category></symtomp><symtomp><id>3709</id><symptom>epilepsy</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1896</id><symptom>hypertonia, spasticity</symptom><category>MUSCLES</category></symtomp><symtomp><id>1897</id><symptom>hypotonia</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>1951</id><symptom>irritability</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1953</id><symptom>lethargy, drowsiness, apathy</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4070</id><symptom>maculopathy</symptom><category>EYES</category></symtomp><symtomp><id>2424</id><symptom>mental retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1886</id><symptom>microcephaly (&lt;2 SD for age)</symptom><category>HEAD</category></symtomp><symtomp><id>1941</id><symptom>motor retardation / motor developmental delay</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2213</id><symptom>MRI, brain, abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>2426</id><symptom>MRI, brain, white matter abnormalities [-]</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3357</id><symptom>muscle atrophy / muscular atrophy</symptom><category>MUSCLES</category></symtomp><symtomp><id>1900</id><symptom>myoclonus</symptom><category>MUSCLES | NERVOUS SYSTEM</category></symtomp><symtomp><id>2506</id><symptom>onset, adolescent / adolescence</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1915</id><symptom>onset, adulthood / adoulthood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2507</id><symptom>onset, childhood / childhood</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2554</id><symptom>onset, fetus / fetal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2505</id><symptom>onset, infancy / infancy</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>2504</id><symptom>onset, neonatal / neonatal</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>3783</id><symptom>onset, variable age</symptom><category>GENERAL TOPICS</category></symtomp><symtomp><id>1739</id><symptom>optic atrophy</symptom><category>EYES | NERVOUS SYSTEM</category></symtomp><symtomp><id>3680</id><symptom>psychomotor retardation</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1958</id><symptom>psychosis</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1970</id><symptom>pyramidal signs</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>1730</id><symptom>retinal or macular degeneration</symptom><category>EYES</category></symtomp><symtomp><id>2375</id><symptom>retinopathy</symptom><category>EYES</category></symtomp><symtomp><id>1943</id><symptom>seizures</symptom><category>NERVOUS SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>4041</id><symptom>seizures, myoclonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>4056</id><symptom>seizures, tonic clonic</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>3166</id><symptom>skin biopsy, abnormal</symptom><category>LABORATORY FINDINGS | SKIN</category></symtomp><symtomp><id>1874</id><symptom>speech development, delayed, abnormal</symptom><category>GENERAL TOPICS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3479</id><symptom>speech difficulties</symptom><category>LUNG OR RESPIRATORY SYSTEM | NERVOUS SYSTEM</category></symtomp><symtomp><id>1944</id><symptom>tremor or twitching</symptom><category>NERVOUS SYSTEM</category></symtomp><symtomp><id>2393</id><symptom>VEP (visual evoked potentials), abnormal</symptom><category>LABORATORY FINDINGS | NERVOUS SYSTEM</category></symtomp><symtomp><id>3902</id><symptom>white matter changes, abnormalities</symptom><category>NERVOUS SYSTEM</category></symtomp></Symptoms><Metabolites /><Literatures><literature><id>4547</id><title>NCLs and ER: A stressful relationship</title><author>Marotta D,</author><journal>Biochim Biophys Acta</journal><year>2017</year><book /><volume>1863</volume><number>6</number><pages>1273-1281</pages><co_aut>Tinelli E, Mole SE</co_aut></literature><literature><id>4548</id><title>Neuronal ceroid lipofuscinoses</title><author>Nita DA,</author><journal>Epileptic Disord</journal><year>2016</year><book /><volume>18</volume><number>2</number><pages>73-88</pages><co_aut>Mole SE, Minassian BA</co_aut></literature><literature><id>5001</id><title>Human NCL Neuropathology</title><author>Radke J,</author><journal>Biochim Biophys Acta</journal><year>2015</year><book /><volume>1852</volume><number>10</number><pages>2262-2266</pages><co_aut>Stenzel W, Goebel HH</co_aut></literature><literature><id>4549</id><title>Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease)</title><author>Hawkins-Salsbury JA,</author><journal>Biochim Biophys Acta</journal><year>2013</year><book /><volume>1832</volume><number>11</number><pages>1906-1909</pages><co_aut>Cooper JD, Sands MS</co_aut></literature><literature><id>5002</id><title>Neuronal Ceroid-Lipofuscinoses</title><author>Mole SE,</author><journal>Source  GeneReviews&#174; [Internet]</journal><year>2013</year><book /><volume>0</volume><number>0</number><pages /><co_aut>Williams RE</co_aut></literature><literature><id>2881</id><title>Children with infantile neuronal ceroid lipofuscinosis have an increased risk of hypothermia and bradycardia during anesthesia&lt;</title><author>Miao N</author><journal>Anesth Analg</journal><year>2009</year><book /><volume>109</volume><number>2</number><pages>372-378</pages><co_aut>et al.</co_aut></literature><literature><id>2884</id><title>A 30-year follow-up of a neuronal ceroid lipofuscinosis patient with mutations in CLN3 and protracted disease course</title><author>Aberg L</author><journal>Pediatr Neurol</journal><year>2009</year><book /><volume>40</volume><number>2</number><pages>134-137</pages><co_aut>et al.</co_aut></literature><literature><id>2880</id><title>The function of CLN3P, the Batten disease protein</title><author>Rakheja D</author><journal>Mol Genet Metab</journal><year>2008</year><book /><volume>93</volume><number>3</number><pages>269-274</pages><co_aut>Narayan SB, Bennett MJ</co_aut></literature><literature><id>2882</id><title>Treatment of seizures in a patient with Battens disease</title><author>Patel NC</author><journal>Nurse Pract</journal><year>2008</year><book /><volume>33</volume><number>10</number><pages>6-9</pages><co_aut>Davenport RD, Patel HN</co_aut></literature><literature><id>2883</id><title>Treatment of late infantile neuronal ceroid lipofuscinosis by CNS administration of a serotype 2 adeno-associated virus express</title><author>Worgall S</author><journal>Hum Gene Ther</journal><year>2008</year><book /><volume>19</volume><number>5</number><pages>463-474</pages><co_aut>et al.</co_aut></literature><literature><id>2206</id><title>AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis</title><author>Griffey M</author><journal>Mol Ther</journal><year>2005</year><book /><volume>0</volume><number>0</number><pages /><co_aut>et al.</co_aut></literature><literature><id>2207</id><title>[From gene to disease; from CLN1, CLN2 and CLN3 to neuronal ceroid lipofuscinosis]</title><author>Taschner PE</author><journal>Ned Tijdschr Geneeskd</journal><year>2005</year><book /><volume>149</volume><number>6</number><pages>300-303</pages><co_aut>et al.</co_aut></literature><literature><id>2208</id><title>The genetic spectrum of human neuronal ceroid-lipofuscinoses</title><author>Mole SE</author><journal>Brain Pathol</journal><year>2004</year><book /><volume>14</volume><number>1</number><pages>70-76</pages><co_aut /></literature><literature><id>2209</id><title>Current state of clinical and morphological features in human NCL</title><author>Goebel HH</author><journal>Brain Pathol</journal><year>2004</year><book /><volume>14</volume><number>1</number><pages>61-69</pages><co_aut>Wisniewski KE</co_aut></literature><literature><id>2210</id><title>Neuronal ceroid lipofuscinoses in childhood</title><author>Santavuori P</author><journal>Suppl Clin Neurophysiol</journal><year>2000</year><book /><volume>53</volume><number>0</number><pages>443-451</pages><co_aut>et al.</co_aut></literature><literature><id>2211</id><title>Neuronal ceroid lipofuscinoses in childhood</title><author>Santavuori P</author><journal>Neurol Sci (Suppl)</journal><year>2000</year><book /><volume>21</volume><number>0</number><pages>S35-41</pages><co_aut>et al.</co_aut></literature><literature><id>2205</id><title>First-trimester diagnosis of infantile neuronal ceroid lipofuscinosis (INCL) using PPT enzyme assay and CLN1 mutation analysis&lt;</title><author>de Vries BB</author><journal>Prenat Diagn</journal><year>1999</year><book /><volume>19</volume><number>6</number><pages>559-562</pages><co_aut>et al.</co_aut></literature><literature><id>573</id><title>Lysosomal targeting of palmitoyl-protein thioesterase</title><author>Verkruyse LA</author><journal>J Biol Chem</journal><year>1996</year><book /><volume>271</volume><number>26</number><pages>15831-6</pages><co_aut>Hofmann-SL</co_aut></literature><literature><id>591</id><title>Neuroradiological findings in classical late infantile neuronal ceroid-lipofuscinosis</title><author>Petersen B</author><journal>Pediatr Neurol</journal><year>1996</year><book /><volume>15</volume><number>0</number><pages>344-377</pages><co_aut>Handwerker M, Huppertz HI</co_aut></literature><literature><id>562</id><title>The neuronal ceroid-lipofuscinoses</title><author>Goebel HH</author><journal>J Child Neurol</journal><year>1995</year><book>inf neur ceroid-lipofuscinosis CLN1 1p32 juv neu cereid-lipofuscinosis, CLN3 6p12.1-11.2 late inf neu 13q31-32</book><volume>10</volume><number>6</number><pages>424-437</pages><co_aut /></literature><literature><id>568</id><title>Neuronal ceroid-lipofuscinosis: a clinical and morphological study of 19 patients</title><author>Nardocci N</author><journal>Am J Med Genet</journal><year>1995</year><book /><volume>57</volume><number>2</number><pages>137-141</pages><co_aut>et al.</co_aut></literature><literature><id>569</id><title>Significance of lipopigments with fingerprint profiles in eccrine sweat gland epithelial cells</title><author>Goebel HH</author><journal>Am J Med Genet</journal><year>1995</year><book /><volume>57</volume><number>2</number><pages>187-190</pages><co_aut>et al.</co_aut></literature><literature><id>570</id><title>Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis</title><author>Vesa J</author><journal>Nature</journal><year>1995</year><book /><volume>376</volume><number>0</number><pages>584-587</pages><co_aut>et al.</co_aut></literature><literature><id>571</id><title>Rapid detection of subunit c of mitochondrial ATP synthase in urine as a diagnostic screening method for neuronal ceroid-lipofus</title><author>Wisniewski KE</author><journal>Am J Med Genet</journal><year>1995</year><book /><volume>57</volume><number>2</number><pages>246-249</pages><co_aut>et al.</co_aut></literature><literature><id>572</id><title>Diagnoses of neuronal ceroid-lipofuscinosis by immunochemical methods</title><author>Hosain S</author><journal>Am J Med Genet</journal><year>1995</year><book /><volume>57</volume><number>2</number><pages>239-245</pages><co_aut>et al.</co_aut></literature><literature><id>667</id><title>Valproate-associated acute pancreatitis in a child with neuronal ceroid lipofuscinosis</title><author>Talwar D</author><journal>J Child Neurol</journal><year>1994</year><book /><volume>9</volume><number>1</number><pages>36-37</pages><co_aut /></literature><literature><id>567</id><title>Human forms of neuronal ceroid-lipofuscinosis (Batten disease): consensus on diagnositic criteria, Hamburg 1992</title><author>Kohlsch&#252;tter A</author><journal>J Inherit Metab Dis</journal><year>1993</year><book /><volume>16</volume><number>0</number><pages>241-244</pages><co_aut>Gardiner RM, Goebel HH</co_aut></literature></Literatures></Disease>